ChAdTS-S

ChAdTS-S is a recombinant viral vector vaccine candidate developed using a chimpanzee adenovirus (ChAd) platform, engineered to express the spike (S) protein of a target pathogen. The "ChAd" prefix indicates the use of a non-replicating chimpanzee adenoviral vector, while "S" typically refers to the spike protein antigen. This design is similar in concept to other ChAd-based vaccines used for infectious diseases such as COVID-19 and polio. The primary mechanism involves delivery of genetic material encoding the S protein into host cells, leading to expression of the antigen and induction of an immune response. Specific details about its developer, manufacturing status, or clinical development phase are not available in public sources.